RECURSION
LIVE

Serial Number

97697670

Owner

RECURSION PHARMACEUTICALS, INC.

Attorney

David P. Johnson

First Use Date

Nov 16, 2013

Filing Date

Nov 30, 2022

Add to watchlist:

No watchlists yet
View on USPTO

RECURSION Trademark

Serial Number: 97697670

RECURSION is a trademark filed by RECURSION PHARMACEUTICALS, INC. on November 30, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

RECURSION PHARMACEUTICALS, INC. (37 trademarks)

41 SOUTH RIO GRANDE STREET
SALT LAKE CITY, UT 84101

Entity Type: 03

Trademark Details

Filing Date

November 30, 2022

Registration Date

Not Registered

First Use Anywhere

November 16, 2013

First Use in Commerce

November 16, 2013

Published for Opposition

July 16, 2024

Goods & Services

Providing temporary use of online, non-downloadable computer software for data processing for use in diagnosing medical conditions, prescribing medical treatment and prescriptions, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for use in consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 24, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 23, 2026 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 23, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Sep 3, 2025 EEXT
TEAS STATEMENT OF USE RECEIVED
Sep 3, 2025 EISU
SOU EXTENSION 2 FILED
Sep 2, 2025 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 10, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 10, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 10, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 29, 2024 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 28, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 2, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 13, 2024 XAEC
ASSIGNED TO LIE
Mar 13, 2024 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 13, 2024 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 11, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 27, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 8, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 16, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 16, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 16, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 12, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2022 NWOS
NEW APPLICATION ENTERED
Dec 3, 2022 NWAP